Emerging VEGF-receptor inhibitors for colorectal cancer

By Martinelli Erika   Troiani Teresa   Morgillo Floriana   Orditura Michele   De Vita Fernando   Belli Giulio   Ciardiello Fortunato  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 25-37

Informa Healthcare

Access to resources Recommend Favorite

VEGF inhibitors for the treatment of neovascular age-related macular degeneration

By Barakat Mark Rami   Kaiser PK  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. : 637-646

Informa Healthcare

Access to resources Recommend Favorite

Kinase insert domain-containing receptor kinase inhibitors as anti-angiogenic agents

By Hartman George D   Fraley Mark E   Bilodeau Mark T  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 737-745

Informa Healthcare

Access to resources Recommend Favorite

Some Implications of Receptor Kinase Signaling Pathway for Development of Multitargeted Kinase Inhibitors

By  

Current Radiopharmaceuticals, Vol. 6, Iss. 1, 2013-03 ,pp. : 48-55

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Strategies - from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2680-2701

Bentham Science Publishers

Access to resources Recommend Favorite